| "Actinobacterium bifidum" (Tissier 1900) Puntoni 1937| "Actinomyces bifidus" (Tissier 1900) Nannizzi 1934| "Actinomyces parabifidus" (Weiss and Rettger 1938) Pine and Georg 1965| "Bacillus bifidus communis" Tissier 1900| "Bacillus bifidus" Tissier 1900| "Bacterium bifidum" (Tissier 1900) Lehmann and Neumann 1927| "Bacteroides bifidus" (Tissier 1900) Castellani and Chalmers 1919| "Bifidibacterium bifidum" (Tissier 1900) Prevot 1938| "Cohnistreptothrix bifidus" (Tissier 1900) Negroni and Fischer 1944| "Lactobacillus bifidus type II" Weiss and Rettger 1938| "Lactobacillus parabifidus" Weiss and Rettger 1938| "Nocardia bifida" (Tissier 1900) Vuillemin 1931| "Tissieria bifida" (Tissier 1900) Pribram 1929| Actinobacterium bifidum| Actinomyces bifidus| Actinomyces parabifidus| AS 1.2212| ATCC 29521| Bacillus bifidus| Bacillus bifidus communis| Bacterium bifidum| Bacteroides bifidus| BCRC 14615| Bifidibacterium bifidum| Bifidobacterium bifidum| Bifidobacterium bifidum (Tissier 1900) Orla-Jensen 1924| CCRC 14615| CCRC:14615| CCUG 18364| CCUG 45217| CIP 56.7| Cohnistreptothrix bifidus| DSM 20456| HAMBI 1380| IFO 14252| JCM 1255| KCTC 3202| Lactobacillus bifidus type II| Lactobacillus parabifidus| LMG 11041| LMG 8810| LMG:11041| LMG:8810| NBRC 100015| NBRC 14252| NCFB 2715| NCIMB 702715| NCTC 13001| Nocardia bifida| strain Ti| Tissieria bifida
Gut Health: Bifidobacterium bifidum is known for its ability to contribute to a healthy balance of the gut microbiota. It helps maintain a favorable environment in the intestines by competing with harmful bacteria for resources and producing substances that inhibit the growth of pathogens.
Digestive Health: Bifidobacterium bifidum is involved in the fermentation of nondigestible carbohydrates in the colon, producing short-chain fatty acids (SCFAs) and other metabolites. SCFAs play a role in maintaining the health of the intestinal lining and providing a source of energy for colonocytes.
Immune Modulation: Some research suggests that Bifidobacterium bifidum may have immunomodulatory effects, influencing the activity of the immune system. This can contribute to a balanced immune response and may be particularly important in maintaining immune homeostasis in the gut.
Anti-Inflammatory Effects: Bifidobacterium bifidum, along with other probiotics, has been studied for its potential to reduce inflammation in the gut. This anti-inflammatory activity may be beneficial in conditions associated with intestinal inflammation.
Prevention of Antibiotic-Associated Diarrhea: Probiotics, including Bifidobacterium bifidum, are sometimes used to help prevent or alleviate antibiotic-associated diarrhea. Antibiotics can disrupt the balance of the gut microbiota, and supplementing with probiotics may help restore microbial balance.
Other Sources for more information:
R2 | Slope | Tax Name | Parent Chart |
---|---|---|---|
0.34625864028930664 | 0.6391708254814148 | Bifidobacterium longum | Parent Taxa |
0.31378358602523804 | 0.605810284614563 | Bifidobacterium catenulatum | Parent Taxa |
0.29497256875038147 | 0.5897682905197144 | Bifidobacterium breve | Parent Taxa |
0.29174351692199707 | 0.5850142240524292 | Bifidobacterium adolescentis | Parent Taxa |
R2 | Slope | Tax Name | Parent Chart |
---|---|---|---|
0.2744467854499817 | 0.5029869675636292 | Bifidobacterium longum | Parent Taxa |
0.26507264375686646 | 0.5144981741905212 | Bifidobacterium catenulatum | Parent Taxa |
0.255140483379364 | 0.5781691670417786 | Bifidobacterium angulatum | Parent Taxa |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]